Patents by Inventor Sachin Arora

Sachin Arora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of reducing a fermentation and/or enzyme inhibitor in a saccharide-containing composition
    Patent number: 9410217
    Abstract: Provided is a method of treating a saccharide-containing composition, the method comprising contacting a composition containing a saccharide with a compound of formula (I) or a salt thereof wherein R1-R4, X, and n are as described herein. Further provided is a composition comprising a saccharide and a compound of formula (I) or a salt thereof.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: August 9, 2016
    Assignee: Renmatix, Inc.
    Inventors: Francis Lipiecki, Sachin Arora
  • METHOD OF REDUCING A FERMENTATION AND/OR ENZYME INHIBITOR IN A SACCHARIDE-CONTAINING COMPOSITION
    Publication number: 20150232958
    Abstract: Provided is a method of treating a saccharide-containing composition, the method comprising contacting a composition containing a saccharide with a compound of formula (I) or a salt thereof wherein R1-R4, X, and n are as described herein. Further provided is a composition comprising a saccharide and a compound of formula (I) or a salt thereof.
    Type: Application
    Filed: February 18, 2014
    Publication date: August 20, 2015
    Inventors: Francis Lipiecki, Sachin Arora
  • PULSATILE RELEASE PHARMACEUTICAL FORMULATION OF DEXLANSOPRAZOLE
    Publication number: 20120164233
    Abstract: The present invention relates to a pulsatile-release pharmaceutical formulation of dexlansoprazole composed of a single type of enteric coated pellets and the process for the preparation thereof.
    Type: Application
    Filed: July 28, 2011
    Publication date: June 28, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Ankur BHARGAVA, Sachin ARORA, Ajay Kumar SINGLA
  • PACKAGING FOR SIROLIMUS AND COMPOSITION THEREOF
    Publication number: 20100268187
    Abstract: The present invention relates to a packaging kit used for the stabilization of sirolimus particles wherein the packaging kit is in the form of a vacuum sealed impermeable container. It further relates to a method for stabilization of sirolimus particles as well as composition comprising the particles.
    Type: Application
    Filed: April 16, 2010
    Publication date: October 21, 2010
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Ajay K. SINGLA, Sachin Arora, Mohit Mittal
  • BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR
    Publication number: 20100178341
    Abstract: The present invention relates to a bilayered tablet comprising: a slow release layer comprising niacin and release retarding agent; and an immediate release layer comprising HMG-CoA reductase inhibitor.
    Type: Application
    Filed: June 10, 2009
    Publication date: July 15, 2010
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Chayapathy ISSA, Praveen Raheja, Sachin Arora, Rajesh Gandhi, Rajeev Shanker Mathur
  • EXTENDED RELEASE TABLET FORMULATION OF NIACIN
    Publication number: 20100144800
    Abstract: The present invention relates to an extended release tablet formulation comprising niacin and a release retarding agent selected from hydroxypropyl cellulose, polyethylene oxide or mixtures thereof.
    Type: Application
    Filed: June 10, 2009
    Publication date: June 10, 2010
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Chayapathy Issa, Praveen Raheja, Sachin Arora, Rajesh Gandhi, Rajeev Shanker Mathur
  • OXCARBAZEPINE DOSAGE FORMS
    Publication number: 20090196919
    Abstract: The present invention relates to dosage forms of oxcarbazepine for oral administration that contain oxcarbazepine having a median particle size of from about 14 ?m to about 30 ?m and to processes for the preparation of such dosage forms. The dosage form may be a solid or a liquid dosage form. The solid dosage form may be in the form of a tablet, a capsule, or a granulate. The liquid dosage form may be in the form of a solution or a suspension.
    Type: Application
    Filed: October 24, 2005
    Publication date: August 6, 2009
    Inventors: Ajay Singla, Sachin Arora, Rahul Dabre